Mirror Now
@mirrornow·2.2M subscribers·145K videos
Oxford vaccine result gives world ray of hope, Pune-based manufacturer plans to apply for license
Posted
July 21, 2020
Views
119
Likes
3
Engagement
2.52%
July 21, 2020
119
3
2.52%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
4:33Now PlayingOxford-AstraZeneca's vaccine candidate has shown positive results in early trials. The Serum Institute of India (SII) has now announced that it is seeking a license from Indian regulators to begin its own clinical trials of the inoculant within a week, following news of the COVID-19 vaccine developed by Oxford University and pharma giant AstraZeneca showing promising results in producing an immune response against the virus. The Serum Institute of India (SII) is likely to begin trials in India by August, this year. The pharma giant of India is also eyeing the license for the production of the vaccine. More than 14.6 million people all around the world have been affected by the coronavirus infection, with 1.16 million of these being from India.
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
